BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Post-LOEbisoprolol fumarate and hydrochlorothiazide
ANDAORALTABLET
Approved
Jul 2020
Lifecycle
Post-LOE
Competitive Pressure
30/100
Mechanism of Action
CLINICAL PHARMACOLOGY Bisoprolol fumarate and HCTZ have been used individually and in combination for the treatment of hypertension. The antihypertensive effects of these agents are additive; HCTZ 6.25 mg significantly increases the antihypertensive effect of bisoprolol fumarate. The incidence of…
Pharmacologic Class:
Thiazide Diuretic